Latest Research in Chronic Lymphocytic Leukemia Research

20 research papers · 2026 median publication year

Top Research Topics in Chronic Lymphocytic Leukemia Research

Highest-Cited Papers

  1. The NSDHL/c-Myc/PKM2 Axis Drives Glycolytic Reprogramming and Tumor Growth in Multiple Myeloma
  2. Identification of broadly tumour-reactive γδ TCRs from multiple myeloma
  3. Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany—A Multi‐Center Analysis
  4. A study of ubiquitination and liquid-liquid phase separation related genes yields uba1 as a primary candidate biomarker for a role in multiple myeloma
  5. FASTINA – protocol for a randomised feasibility trial of time-restricted eating to improve response to multiple myeloma therapy
  6. Hypophosphatemia after CAR-T cell therapy: a prospective study of inflammation, tubular injury and phosphate handling
  7. Not all anti‐ CD38 antibodies are created equal: The epitope of felzartamab is partially DTT ‐resistant
  8. PTPN2 Deletion Enhances CAR-T Effector Function and CNS Trafficking in a Non-Human Primate Model
  9. Spatial profiling identifies a distinct and topographically-defined tumor microenvironment that emerges during multiple myeloma evolution
  10. Physiologically Based Pharmacokinetic Modeling to Predict Human Starting Dose and Pharmacokinetics for Rocbrutinib
  11. Anti‐ BCMA CAR ‐ NK Cells Reveal Enhanced Cytolytic and Secretory Responses Against Myeloma Cells
  12. Primary Plasma Cell Leukemia
  13. IFI27 and BAX are Essential for GSDME‐Mediated Myeloma Cell Pyroptosis
  14. A Machine Learning Approach That Measures Extracellular pH Within an In Vivo Tumor Model Using acidoCEST MRI
  15. Comprehensive Analyses of SOX7 Provide Novel Insights on Its Tumor Suppressor Role and Its Target Genes with Therapeutic Implications in Multiple Myeloma
  16. Epigenomic profiling of H3K27ac in a primary patient-derived multiple myeloma cell line using two different low-input methods with concordant results
  17. Exploratory analysis of a novel obesity-related gene-based prognostic model as a potential prognostic biomarker in multiple myeloma
  18. SEI1 complex silences p53 to drive myeloma progression
  19. Late-Onset Neutropenia and Hypogammaglobulinemia After Dose-Adjusted R-EPOCH in Unfavorable Diffuse Large B-Cell Lymphoma
  20. Development of a Homogeneous Trastuzumab-Triptolide Conjugate for Targeted Therapy of HER2-Overexpressing Ovarian Cancer
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
L3 Region - - 2026 Sep Q3

Chronic Lymphocytic Leukemia Research

20 papers

Top Topics (10)

Multiple Myeloma Research and Treatments6
Chronic Lymphocytic Leukemia Research4
CAR-T cell therapy research2
Dietary Effects on Health1
Occupational and environmental lung diseases1
Immune Cell Function and Interaction1
Inflammasome and immune disorders1
Lanthanide and Transition Metal Complexes1
Ferroptosis and cancer prognosis1
Ubiquitin and proteasome pathways1

Top Publications (20)

1.The NSDHL/c-Myc/PKM2 Axis Drives Glycolytic Reprogramming and Tumor Growth in Multiple Myeloma2.Identification of broadly tumour-reactive γδ TCRs from multiple myeloma3.Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany—A Multi‐Center Analysis4.A study of ubiquitination and liquid-liquid phase separation related genes yields uba1 as a primary candidate biomarker for a role in multiple myeloma5.FASTINA – protocol for a randomised feasibility trial of time-restricted eating to improve response to multiple myeloma therapy6.Hypophosphatemia after CAR-T cell therapy: a prospective study of inflammation, tubular injury and phosphate handling7.Not all anti‐ CD38 antibodies are created equal: The epitope of felzartamab is partially DTT ‐resistant8.PTPN2 Deletion Enhances CAR-T Effector Function and CNS Trafficking in a Non-Human Primate Model9.Spatial profiling identifies a distinct and topographically-defined tumor microenvironment that emerges during multiple myeloma evolution10.Physiologically Based Pharmacokinetic Modeling to Predict Human Starting Dose and Pharmacokinetics for Rocbrutinib11.Anti‐ BCMA CAR ‐ NK Cells Reveal Enhanced Cytolytic and Secretory Responses Against Myeloma Cells12.Primary Plasma Cell Leukemia13.IFI27 and BAX are Essential for GSDME‐Mediated Myeloma Cell Pyroptosis14.A Machine Learning Approach That Measures Extracellular pH Within an In Vivo Tumor Model Using acidoCEST MRI15.Comprehensive Analyses of SOX7 Provide Novel Insights on Its Tumor Suppressor Role and Its Target Genes with Therapeutic Implications in Multiple Myeloma16.Epigenomic profiling of H3K27ac in a primary patient-derived multiple myeloma cell line using two different low-input methods with concordant results17.Exploratory analysis of a novel obesity-related gene-based prognostic model as a potential prognostic biomarker in multiple myeloma18.SEI1 complex silences p53 to drive myeloma progression19.Late-Onset Neutropenia and Hypogammaglobulinemia After Dose-Adjusted R-EPOCH in Unfavorable Diffuse Large B-Cell Lymphoma20.Development of a Homogeneous Trastuzumab-Triptolide Conjugate for Targeted Therapy of HER2-Overexpressing Ovarian Cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.